Breaking News
November 19, 2017 - Dental filling failure linked to smoking, drinking and genetics
November 19, 2017 - Medicaid expansion takes a bite out of medical debt
November 19, 2017 - Study aims to involve parents in early intervention services for children with autism
November 19, 2017 - Don’t Fret Delays in Treating Colon Cancer, Study Suggests
November 19, 2017 - Yeast Infection Test: MedlinePlus Lab Test Information
November 19, 2017 - Video of blood clot contraction reveals how platelets naturally form unobtrusive clots
November 19, 2017 - UNN researchers explore modeling of cognitive dissonance phenomenon
November 19, 2017 - Verseon presents second anticoagulation candidate for clinical trials at AHA 2017
November 19, 2017 - Pregnant Asian women who develop high blood pressure at highest risk for heart failure hospitalization
November 19, 2017 - Medicare seeks comment on ways to cut costs of Part D drugs
November 19, 2017 - Tree cover linked to fewer asthma cases in polluted urban neighborhoods
November 19, 2017 - Make the Diagnosis: Hair Care Conundrum
November 19, 2017 - New techniques give blood biopsies greater promise
November 19, 2017 - Researchers identify possible genetic basis for coronary artery disease
November 19, 2017 - Stress experienced by emergency call handlers has negative impact on psychological health
November 18, 2017 - New cancer cell screening is improving childhood leukaemia treatment
November 18, 2017 - Groundbreaking study identifies protein as potential factor in cancer metastasis
November 18, 2017 - New model to test effectiveness of existing and potential CF therapies
November 18, 2017 - Staying Active May Lower Odds for Glaucoma
November 18, 2017 - Potential new autism drug shows promise in mice
November 18, 2017 - Some states roll back ‘retroactive Medicaid,’ a buffer for the poor — and for hospitals
November 18, 2017 - Selectively deleting stem cell factor promotes recovery after TBI in mice
November 18, 2017 - Breakthrough research brings new procedure closer to helping patients with blood cancer
November 18, 2017 - Dr Peter Simpson Appointed to SLAS Board of Directors
November 18, 2017 - Friendships between young children can protect against ADHD
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study shows how naïve T-cells may affect tumor immunity and immunotherapy
November 18, 2017 - New studies highlight importance of cardiorespiratory fitness to reduce CVD risk
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - Leaf-eating ability of beetle largely due to bacteria inside the insect
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
Getting a Handle on Benign MS

Getting a Handle on Benign MS

image_pdfDownload PDFimage_print

PARIS — The debate over what exactly constitutes “benign” multiple sclerosis still rages, with several presentations here — each with different methodologies — coming to markedly different conclusions.

Using a popular definition of an Expanded Disability Status Scale (EDSS) score of 3.5 or lower at 15 years, a prospective British cohort found a prevalence of about 42%, and a Swedish registry study using a similar cutoff found a prevalence of 22% — both involving mostly untreated patients.

But a Welsh registry study that took into account more than just the EDSS — including fatigue, depression, and cognition — put the prevalence far lower, at around 1%. Meanwhile, a U.S. retrospective chart review that included patients treated with disease-modifying therapies counted 31% to still be “benign” at 20 years.

The variance reflects the current wide range reported in the literature, cited across all presentations to be from 6% to 64%.

One thing all the presenters at the joint ECTRIMS-ACTRIMS 2017 meeting agreed on, however, is that there does appear to be a certain subset of MS patients who will have much slower and less debilitating disease progression.

“We shouldn’t put a label on it,” Ali Manouchehrinia, PhD, of the Karolinska Institute, who reported the Swedish data, told MedPage Today. “The conclusion is that there are a group of patients who progress at a much lower rate. They still progress. They are getting worse. MS has an impact. But it’s not as much as it is for the rest.”

By the ‘Standard’ Definition

His study evaluated 11,222 relapsing MS patients in the Swedish National MS Registry, and using a cutoff of an EDSS of 3 or lower found a prevalence of 22% at 15 years that fell to 6% at 25 years.

In further analyses, they found that those without benign MS accumulated an extra 0.2 points on the EDSS per year compared with those with so-called benign MS. By the age of 40, for instance, mean EDSS score in those with benign disease at year 15 was two points lower than in those with non-benign MS.

Cognitive impairment worsened by an extra 0.4 points on the Symbol Digit Modalities Test (SDMT) per year in those without benign disease, so that 10 years into their disease their SDMT scores were 7 points lower than those with benign disease.

Finally, non-benign MS patients had more missed workdays per year than benign MS patients; they also had a 7-fold higher risk of all-cause mortality.

Manouchehrinia said the patients with benign disease were younger at disease onset (age 28 versus 32), slightly more likely to be female (75% versus 70%), had a lower relapse rate within 2 and 5 years of onset, their first relapse was often a sensory relapse, and they were more likely to show complete recovery from their first relapse.

Though benign disease is a “retrospective” diagnosis, he said, further study of these risk factors can help determine which patients will have a less aggressive disease course — an important consideration in the age of more expensive and more potent medications that come with side effects.

Karen Chung, MBBS, of University College London, who presented the prospective British cohort data, said her results support “the idea a very stable ‘benign’ MS does exist.”

Her team recruited 132 patients who had clinically isolated syndrome (CIS) in 1984-1987 and followed them for a mean of 30 years, for both clinical and MRI outcomes. They excluded CIS patients who never developed MS.

After also excluding those lost to follow-up, they ended up with about 80 patients with known MS; 35 had relapsing MS, 25 had secondary progressive MS, and 16 patients had died with an EDSS of 10, indicating their death had to do with their disease.

Chung and colleagues found that over the 30-year study, 32 people had an EDSS of 3.5 or lower, putting the prevalence at 42%. Only three of these patients used a disease-modifying drug, and they were all first-line injectables, Chung said.

Counting Other Factors

Emma Tallantyre, PhD, of Cardiff University in Wales, said the EDSS is a “blunt tool” for assessing the full impact of MS, and proposed a far more stringent definition of truly benign MS. In addition to an EDSS of 3 or less at 15 years, “benign” patients should have no clinically significant fatigue, depression, bladder symptoms, or cognitive impairment; no impact of MS on occupation; and no exposure to disease-modifying drugs.

By that definition, she found a prevalence of 1% in a Welsh cohort of 222 patients with unlimited walking ability, 56 of whom were assessed and included in the study.

Despite the low numbers, she said researchers and clinicians “shouldn’t use the term ‘benign MS’ readily because it could be dismissive and it isn’t representative of what’s really going on. EDSS is a blunt tool; cognition and fatigue aren’t being detected, but they could cause significant disability.”

Andrew Bouley, MD, of Beth Israel Deaconess Medical Center in Boston, and colleagues found that 31% of patients had benign disease defined as EDSS of 3 or less at 20 years — but about half of their patients were on disease-modifying therapy.

Those with more benign disease, he said, were less likely to be on the more aggressive therapies such as natalizumab, rituximab, and the other chemotherapeutic agents.

“The idea that not all MS is the same isn’t new,” Bouley said.

Tallantyre disclosed financial relationships with Biogen, Merck, and Novartis.

Manouchehrinia, Chung, and Bouley disclosed no financial relationships with industry.


Tagged with:

About author

Related Articles